Lupin Limited, a dominant player in the global pharmaceutical landscape, announced its triumph in obtaining the coveted approval from the United States Food and Drug Administration (FDA). This authorization is for Lupin’s Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended-Release Tablets USP in the concentrations of 25 mg, 50 mg, 100 mg, and 200 […]
Granules India Limited announced its receipt of US Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) of Metoprolol Succinate Extended-Release Tablets USP, 25 mg, 50 mg, 100 mg, and 200 mg. The approval positions Granules India more strongly within the approximately $321 million US market for this particular medication. The […]
